Alto Neuroscience Inc. (ANRO)
NYSE: ANRO
· Real-Time Price · USD
3.46
0.32 (10.19%)
At close: Aug 18, 2025, 10:40 AM
Alto Neuroscience Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
PE Ratio | -0.84 | -0.96 | -1.88 | -4.59 | -4.79 | -7.29 | -12.4 | -15.22 | -16.06 | -19.1 | -17.3 |
PEG Ratio | -0.05 | n/a | 0.19 | -0.9 | -0.27 | -0.38 | -0.53 | -2.44 | -0.87 | 1.91 | n/a |
PS Ratio | n/a | n/a | 289.73 | n/a | n/a | n/a | 1.5K | n/a | n/a | n/a | n/a |
PB Ratio | 0.48 | 0.42 | 0.75 | 1.87 | 1.71 | 2.03 | -7.76 | -9.11 | n/a | 15.59 | -13.78 |
P/FCF Ratio | -4.32 | -3.52 | -8.44 | -24.23 | -25.53 | -34.93 | -46.86 | -71.27 | -83.2 | -73.76 | -87.03 |
P/OCF Ratio | -4.32 | -3.53 | -8.77 | -26.3 | -26.27 | -35.64 | -48.29 | -71.67 | -83.87 | -73.96 | -87.92 |
OCF/S Ratio | n/a | n/a | -33.05 | n/a | n/a | n/a | -30.98 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.19 | 0.11 | 0.10 | 0.06 | 0.05 | -2.11 | -0.16 | n/a | n/a | -2.14 |
Quick Ratio | 18.43 | 22.53 | 16.92 | 13.09 | 19.85 | 26.02 | 15.22 | 8.70 | n/a | n/a | 8.85 |
Current Ratio | 18.43 | 22.53 | 16.92 | 13.09 | 19.85 | 26.02 | 15.22 | 8.70 | n/a | n/a | 8.85 |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a |
Interest Coverage | 28.92 | -26.21 | -51.04 | -54.11 | -52.86 | -41.58 | -33.05 | -26.77 | -27.91 | -22.23 | n/a |
Return on Equity | -0.14 | -0.11 | -0.1 | -0.1 | -0.09 | -0.07 | 0.16 | 0.15 | n/a | -0.2 | 0.20 |
Return on Assets | -0.11 | -0.09 | -0.09 | -0.09 | -0.08 | -0.06 | -0.13 | -0.17 | n/a | n/a | -0.15 |
Return on Invested Capital | -0.12 | -0.09 | -0.1 | -0.1 | -0.1 | -0.07 | -0.14 | -0.2 | n/a | n/a | -0.18 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | 0.75 | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -38.58 | n/a | n/a | n/a | -30.15 | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -38.58 | n/a | n/a | n/a | -30.15 | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -43.14 | n/a | n/a | n/a | -31.63 | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -37.3 | n/a | n/a | n/a | -28.95 | n/a | n/a | n/a | n/a |